The purpose of the American Cancer Society Institutional Research Grant (ACS IRG) is to support the initiation of promising new cancer research projects by junior faculty members so they can obtain results that will enable them to compete successfully for peer-reviewed extramural cancer research grants. As a recipient of the ACS IRG, the Hollings Cancer Center (HCC) is able to provide small pilot research funding to early career investigators who have no national competitive research grant support.
Awards will be up to $35,000 each and upon competitive review can be renewed for a second year. The award is exempt from indirect costs, so all funds are used for cancer research as direct costs. Grant awards are for a 12-month period, from January 1, 2018 through December 31, 2018. All awards should be completed and spent by December 31, 2018. No cost extensions will only be granted under rare circumstances.
Applications are no longer being accepted at this time. Please check back for updates.
Each proposal will be reviewed by two or more ACS IRG committee members including a biostatistician and scored by each committee member using the NIH scoring system and process. Written evaluations of the projects will be provided to individual applicants after the funding decisions have been made.
Review criteria will include:
HCC will lead a workshop detailing the ACS IRG application process and advice on submitting exceptional proposals. The event will take place on September 6, 2017 from 2 to 3 p.m. in the HCC Auditorium (120).
Please contact Andie Edwards, Assistant Director of Research Development at firstname.lastname@example.org with questions about your eligibility.